Phase II trial of taxol in patients with metastatic renal cell carcinoma

Avi I. Einzig; Elizabeth Gorowski; Jill Sasloff; Peter H. Wiernik

doi:10.3109/07357909109044223

Phase II trial of taxol in patients with metastatic renal cell carcinoma

Avi I. Einzig, Elizabeth Gorowski, Jill Sasloff, Peter H. Wiernik

Oncology

Research output: Contribution to journal › Article › peer-review

43 Scopus citations

Abstract

Based on results of previous Phase I studies, 18 patients with documented metastastic renal cell carcinoma received Taxol 250 mg/m² as a 24-h infusion, repeated every 21 days in this Phase II study. All patients received premedication with dexamethasone, diphenhydramine, and cimetidine. There were no responses in the 18 patients treated.

Original language	English (US)
Pages (from-to)	133-136
Number of pages	4
Journal	Cancer Investigation
Volume	9
Issue number	2
DOIs	https://doi.org/10.3109/07357909109044223
State	Published - 1991

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3109/07357909109044223

Cite this

@article{abbc6fb5d545471aa3d7ef2721835d5f,

title = "Phase II trial of taxol in patients with metastatic renal cell carcinoma",

abstract = "Based on results of previous Phase I studies, 18 patients with documented metastastic renal cell carcinoma received Taxol 250 mg/m2 as a 24-h infusion, repeated every 21 days in this Phase II study. All patients received premedication with dexamethasone, diphenhydramine, and cimetidine. There were no responses in the 18 patients treated.",

author = "Einzig, {Avi I.} and Elizabeth Gorowski and Jill Sasloff and Wiernik, {Peter H.}",

note = "Funding Information: hesented in part at the annual meeting of the American Society of Clinical Oncology, May 1988. Supported in part by Grant KiP30CAl330-15 awarded by the National Cancer Institute, DHHS.",

year = "1991",

doi = "10.3109/07357909109044223",

language = "English (US)",

volume = "9",

pages = "133--136",

journal = "Cancer Investigation",

issn = "0735-7907",

publisher = "Informa Healthcare",

number = "2",

}

TY - JOUR

T1 - Phase II trial of taxol in patients with metastatic renal cell carcinoma

AU - Einzig, Avi I.

AU - Gorowski, Elizabeth

AU - Sasloff, Jill

AU - Wiernik, Peter H.

N1 - Funding Information: hesented in part at the annual meeting of the American Society of Clinical Oncology, May 1988. Supported in part by Grant KiP30CAl330-15 awarded by the National Cancer Institute, DHHS.

PY - 1991

Y1 - 1991

N2 - Based on results of previous Phase I studies, 18 patients with documented metastastic renal cell carcinoma received Taxol 250 mg/m2 as a 24-h infusion, repeated every 21 days in this Phase II study. All patients received premedication with dexamethasone, diphenhydramine, and cimetidine. There were no responses in the 18 patients treated.

AB - Based on results of previous Phase I studies, 18 patients with documented metastastic renal cell carcinoma received Taxol 250 mg/m2 as a 24-h infusion, repeated every 21 days in this Phase II study. All patients received premedication with dexamethasone, diphenhydramine, and cimetidine. There were no responses in the 18 patients treated.

UR - http://www.scopus.com/inward/record.url?scp=0025878922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025878922&partnerID=8YFLogxK

U2 - 10.3109/07357909109044223

DO - 10.3109/07357909109044223

M3 - Article

C2 - 1677827

AN - SCOPUS:0025878922

SN - 0735-7907

VL - 9

SP - 133

EP - 136

JO - Cancer Investigation

JF - Cancer Investigation

IS - 2

ER -

Phase II trial of taxol in patients with metastatic renal cell carcinoma

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this